2017 Parkinson Study Group Symposium and Training
2017 Parkinson Study Group Symposium and Training
批准号:
9398499
负责人:
MICHAEL A SCHWARZSCHILD
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2018-06-30
关键词:
AdvocateAlzheimer&aposs DiseaseAtaxiaClinicalClinical InvestigatorClinical ResearchClinical TrialsCollaborationsDevelopmentDiseaseDystoniaEducationEducational ActivitiesEducational workshopEnsureEtiologyFosteringFoundationsFutureGilles de la Tourette syndromeGoalsHuntington DiseaseImmunotherapeutic agentImmunotherapyInvestmentsKnowledgeLearningMentorsModificationMovement DisordersNeurobiologyNeurodegenerative DisordersNeurologyParkinson DiseasePathogenesisPatient CarePatientsPeer ReviewPharmacologyProgram ReviewsResearchResearch ActivityResearch MethodologyResearch PersonnelResearch Project GrantsResearch ProposalsScientistTherapeuticTrainingTraining and EducationTranslational ResearchTremorcareercareer developmentdesigndrug developmentexperiencegenetic epidemiologyimprovedinsightmeetingsmobile computingnervous system disorderneuroimagingnovelnovel therapeuticspatient orientedpostersprogramsresearch studyskillssymposiumtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The proposed conference project, centered on the annual clinical research symposium of the
Parkinson Study Group (PSG) and associated annual meeting activities, will foster the
education and training of early stage investigators to ensure that the highest quality translational
and clinical research continues to be conducted toward improved therapy for Parkinson's and
related neurological disease. This project goal will be achieved through two specific aims (SAs).
In SA #1, the PSG will present the “31st Annual Symposium on the Etiology, Pathogenesis, and
Treatment of Parkinson's Disease and Other Movement Disorders” in collaboration with the
Huntington Study Group (HSG), Dystonia Study Group (DSG), Tourette Syndrome Study Group
(TSSG), Cooperative Ataxia Group (CAG), and Tremor Research Group (TRG) on Monday,
September 17, 2017 in Fort Myers, FL. The peer-reviewed program includes both platform and
poster presentations in a live format with audience participation. The symposium will focus on
the emergence of immuno-therapy as a promising strategy for disease modification in
Parkinson's and other neurodegenerative diseases, with keynote talks conveying
complementary neurobiological, drug development, regulatory and patient perspectives. SA #2
is designed to provide early-stage clinical investigators with movement disorders training a
multi-faceted practical orientation to PD clinical research. The selected junior investigators will
participate in several novel and interactive, educational research activities in addition to the
symposium, including a) direct exchange with experienced patient advocates of the Parkinson's
Disease Foundation's PAIR (Parkinson's Advocates in Research) program to learn how patient
input can benefit their research, and b) the PSG Mentoring Committee's junior investigator
workshop on novel research methodologies. Junior investigators completing participation in the
project will be substantially better prepared and motivated to pursue careers and studies in
clinical neurology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Planning for Prevention of Parkinson's Disease: a trial design forum
-
批准号:10827547
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2023
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2019 Parkinson Study Group Symposium and Training
-
批准号:9763271
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:10427325
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:9978147
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:10640903
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:10210454
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2019 Parkinson Study Group Symposium and Training
-
批准号:9890023
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9292399
-
项目类别:
-
资助金额:$338.88万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9258571
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9129755
-
项目类别:
-
资助金额:$533.49万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9547938
-
项目类别:
-
资助金额:$287.4万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2014 Parkinson Study Group Symposium and Training
-
批准号:8838558
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2014
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Role of urate in protecting mitochondrial function in the brain
-
批准号:8676952
-
项目类别:
-
资助金额:$25.23万
-
财政年份:2013
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Role of urate in protecting mitochondrial function in the brain
-
批准号:8597004
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2013
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2013 Parkinson's Study Group Symposium
-
批准号:8651135
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2013
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Uric Acid:novel therapeutic target for Parkinson's Disease
-
批准号:7862626
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2009
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purine pathways to clinical trials for Parkinson's disease
-
批准号:8265936
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purine pathways to clinical trials for Parkinson's disease
-
批准号:7681629
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purinergic pathways to clinical trials for Parkinson's disease
-
批准号:7532911
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purine pathways to clinical trials for Parkinson's disease
-
批准号:8049192
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位: